\-\ Texto\\:\\ \ \(0\)\
\-\ non\\-contributory\ \(73\)\
\-\ surgery\\ and\\ radiation\\ therapy\\.\\ \\ no\\ recurrence\\ at\\ 1\\ year\ \(0\)\
\-\ \\â\\€\\¢\\ a\\ 1\\.5\\ cm\\ mass\\ lying\\ behind\\ cauda\\ equina\\ at\\ l1\\-2\\.\\ \ \(0\)\
\-\ \\â\\€\\¢\\ mass\\ enhances\\ following\\ contrast\\ administration\\.\\ \ \(0\)\
\-\ \\â\\€\\¢\\ no\\ associated\\ bone\\ changes\\ nor\\ neuroforaminal\\ enlargement\\.\ \(0\)\
\-\ ependymoma\\.\\ grade\\ ii\ \(0\)\
\-\ \\â\\€\\¢\\ ependymoma\\ \\(myxopapillary\\)\ \(0\)\
\-\ \\â\\€\\¢\\ herniated\\ disc\ \(0\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ \\â\\€\\¢\\ schwannoma\ \(0\)\
\-\ \\â\\€\\¢\\ meningioma\ \(7\)\
\-\ \\â\\€\\¢\\ paraganglioma\ \(0\)\
\-\ 57\\ year\\ old\\ man\\ with\\ back\\ and\\ right\\ leg\\ pain\\ for\\ 2\\ months\\.\ \(1\)\
\-\ prior\\ to\\ visiting\\ our\\ facility\\,\\ an\\ mri\\ at\\ an\\ outside\\ hospital\\ revealed\\ a\\ mass\\ at\\ l1\\-2\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ependymoma\\:\\ 0\\.2566166934614034\ \(0\)\
\-\ at\\:\\ 0\\.22949640869302068\ \(0\)\
\-\ neuroforaminal\\:\\ 0\\.224461771574772\ \(0\)\
\-\ visiting\\:\\ 0\\.2136648330282456\ \(0\)\
\-\ myxopapillary\\:\\ 0\\.19752432946547716\ \(0\)\
\-\ equina\\:\\ 0\\.17788315615188738\ \(0\)\
\-\ cauda\\:\\ 0\\.17674985631361614\ \(0\)\
\-\ mass\\:\\ 0\\.17406386723778228\ \(0\)\
\-\ paraganglioma\\:\\ 0\\.16522332344533117\ \(0\)\
\-\ herniated\\:\\ 0\\.15616094856023785\ \(0\)\
\-\ lying\\:\\ 0\\.15279793269556693\ \(0\)\
\-\ facility\\:\\ 0\\.15063181814551316\ \(0\)\
\-\ nor\\:\\ 0\\.1478678624307141\ \(0\)\
\-\ behind\\:\\ 0\\.14640839982974943\ \(0\)\
\-\ 57\\:\\ 0\\.14339062388220247\ \(0\)\
\-\ our\\:\\ 0\\.134567071467185\ \(0\)\
\-\ enhances\\:\\ 0\\.1338928955357107\ \(0\)\
\-\ disc\\:\\ 0\\.13196710285193913\ \(0\)\
\-\ schwannoma\\:\\ 0\\.13017124089073148\ \(0\)\
\-\ recurrence\\:\\ 0\\.12541294178373055\ \(0\)\
\-\ outside\\:\\ 0\\.12193801251526191\ \(0\)\
\-\ administration\\:\\ 0\\.12096453759312069\ \(0\)\
\-\ ii\\:\\ 0\\.11976304686759619\ \(0\)\
\-\ enlargement\\:\\ 0\\.11645318177290757\ \(0\)\
\-\ an\\:\\ 0\\.11617118738267516\ \(0\)\
\-\ leg\\:\\ 0\\.11466985265276546\ \(0\)\
\-\ meningioma\\:\\ 0\\.11382106280432018\ \(0\)\
\-\ hospital\\:\\ 0\\.11220057645653005\ \(0\)\
\-\ grade\\:\\ 0\\.10922846046212988\ \(0\)\
\-\ back\\:\\ 0\\.10130555851028147\ \(0\)\
\-\ radiation\\:\\ 0\\.10066076848606058\ \(0\)\
\-\ revealed\\:\\ 0\\.09959923295003154\ \(0\)\
\-\ no\\:\\ 0\\.09879152686547277\ \(0\)\
\-\ year\\:\\ 0\\.09362444301339218\ \(0\)\
\-\ changes\\:\\ 0\\.09180130436375207\ \(0\)\
\-\ following\\:\\ 0\\.09112484478003847\ \(0\)\
\-\ months\\:\\ 0\\.08841739457822159\ \(0\)\
\-\ therapy\\:\\ 0\\.08727571598310194\ \(0\)\
\-\ cm\\:\\ 0\\.08723720762220381\ \(0\)\
\-\ prior\\:\\ 0\\.08498764904868673\ \(0\)\
\-\ metastatic\\:\\ 0\\.083308896705432\ \(0\)\
\-\ bone\\:\\ 0\\.08288072316370504\ \(0\)\
\-\ surgery\\:\\ 0\\.08166722299995759\ \(0\)\
\-\ man\\:\\ 0\\.08041711411232232\ \(0\)\
\-\ associated\\:\\ 0\\.08006206182662126\ \(0\)\
\-\ mri\\:\\ 0\\.0779713692194098\ \(0\)\
\-\ contrast\\:\\ 0\\.07380452865639484\ \(0\)\
\-\ disease\\:\\ 0\\.06376172268840069\ \(0\)\
\-\ and\\:\\ 0\\.06277605731286562\ \(0\)\
\-\ pain\\:\\ 0\\.05435498301266747\ \(0\)\
\-\ right\\:\\ 0\\.05036073926847249\ \(0\)\
\-\ for\\:\\ 0\\.046039362451201174\ \(0\)\
\-\ old\\:\\ 0\\.04495593709904181\ \(0\)\
\-\ to\\:\\ 0\\.03797440323008699\ \(0\)\
\-\ with\\:\\ 0\\.029743685312841606\ \(0\)\
